BNP Paribas Financial Markets’s NRC Health Common Stock NRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $88.4K | Buy |
4,096
+1,497
| +58% | +$27.8K | ﹤0.01% | 4622 |
|
|
2026
Q1 | $44.1K | Sell |
2,599
-26
| -1% | -$442 | ﹤0.01% | 4763 |
|
|
2025
Q4 | $49.3K | Buy |
2,625
+129
| +5% | +$1.95K | ﹤0.01% | 4690 |
|
|
2025
Q3 | $31.9K | Buy |
2,496
+1,150
| +85% | +$17.2K | ﹤0.01% | 4781 |
|
|
2025
Q2 | $22.6K | Buy |
1,346
+423
| +46% | +$5.71K | ﹤0.01% | 4543 |
|
|
2025
Q1 | $11.8K | Sell |
923
-1,155
| -56% | -$18.5K | ﹤0.01% | 4675 |
|
|
2024
Q4 | $36.7K | Sell |
2,078
-2,694
| -56% | -$51.1K | ﹤0.01% | 4546 |
|
|
2024
Q3 | $109K | Sell |
4,772
-24,275
| -84% | -$548K | ﹤0.01% | 3433 |
|
|
2024
Q2 | $667K | Buy |
29,047
+21,554
| +288% | +$664K | ﹤0.01% | 2504 |
|
|
2024
Q1 | $297K | Sell |
7,493
-3,986
| -35% | -$158K | ﹤0.01% | 3117 |
|
|
2023
Q4 | $454K | Buy |
11,479
+2,095
| +22% | +$87.7K | ﹤0.01% | 2843 |
|
|
2023
Q3 | $416K | Buy |
9,384
+5,658
| +152% | +$247K | ﹤0.01% | 2818 |
|
|
2023
Q2 | $162K | Sell |
3,726
-2,278
| -38% | -$100K | ﹤0.01% | 3088 |
|
|
2023
Q1 | $261K | Buy |
6,004
+1,974
| +49% | +$87.2K | ﹤0.01% | 3042 |
|
|
2022
Q4 | $150K | Sell |
4,030
-2,314
| -36% | -$89.5K | ﹤0.01% | 3103 |
|
|
2022
Q3 | $252K | Buy |
6,344
+2,848
| +81% | +$105K | ﹤0.01% | 3384 |
|
|
2022
Q2 | $134K | Buy |
3,496
+971
| +38% | +$35.1K | ﹤0.01% | 3254 |
|
|
2022
Q1 | $100K | Sell |
2,525
-2,552
| -50% | -$99.9K | ﹤0.01% | 3359 |
|
|
2021
Q4 | $211K | Buy |
5,077
+2,582
| +103% | +$112K | ﹤0.01% | 3380 |
|
|
2021
Q3 | $105K | Buy |
2,495
+2,005
| +409% | +$101K | ﹤0.01% | 3254 |
|
|
2021
Q2 | $22.5K | Sell |
490
-1,262
| -72% | -$60K | ﹤0.01% | 3503 |
|
|
2021
Q1 | $82K | Sell |
1,752
-782
| -31% | -$38K | ﹤0.01% | 3437 |
|
|
2020
Q4 | $108K | Sell |
2,534
-600
| -19% | -$30.8K | ﹤0.01% | 3171 |
|
|
2020
Q3 | $154K | Buy |
3,134
+2,632
| +524% | +$146K | ﹤0.01% | 2887 |
|
|
2020
Q2 | $29.2K | Sell |
502
-3,445
| -87% | -$182K | ﹤0.01% | 3243 |
|
|
2020
Q1 | $180K | Buy |
3,947
+1,920
| +95% | +$115K | ﹤0.01% | 2917 |
|
|
2019
Q4 | $134K | Sell |
2,027
-43
| -2% | -$2.63K | ﹤0.01% | 3152 |
|
|
2019
Q3 | $120K | Buy |
2,070
+737
| +55% | +$45.7K | ﹤0.01% | 3031 |
|
|
2019
Q2 | $76.8K | Sell |
1,333
-976
| -42% | -$45.2K | ﹤0.01% | 3186 |
|
|
2019
Q1 | $89.1K | Buy |
2,309
+2,287
| +10,395% | +$89.6K | ﹤0.01% | 3188 |
|
|
2018
Q4 | $839 | Sell |
22
-305
| -93% | -$11.7K | ﹤0.01% | 3945 |
|
|
2018
Q3 | $12.6K | Sell |
327
-53
| -14% | -$2.01K | ﹤0.01% | 3629 |
|
|
2018
Q2 | $14.2K | Sell |
380
-1,670
| -81% | -$58.2K | ﹤0.01% | 3636 |
|
|
2018
Q1 | $60K | Buy |
2,050
+103
| +5% | +$3.46K | ﹤0.01% | 3470 |
|
|
2017
Q4 | $72.6K | Buy |
1,947
+1,192
| +158% | +$42.3K | ﹤0.01% | 3469 |
|
|
2017
Q3 | $28.5K | Sell |
755
-54
| -7% | -$1.7K | ﹤0.01% | 3421 |
|
|
2017
Q2 | $21.8K | Buy |
809
+802
| +11,457% | +$19.6K | ﹤0.01% | 3612 |
|
|
2017
Q1 | $138 | Sell |
7
-71
| -91% | -$1.31K | ﹤0.01% | 3981 |
|
|
2016
Q4 | $1.48K | Sell |
78
-509
| -87% | -$8.4K | ﹤0.01% | 3973 |
|
|
2016
Q3 | $9.56K | Buy |
587
+301
| +105% | +$4.73K | ﹤0.01% | 3180 |
|
|
2016
Q2 | $3.92K | Buy |
+286
| New | +$4.03K | ﹤0.01% | 3355 |
|
|
2016
Q1 | – | Sell |
-963
| Closed | -$15.4K | – | 2942 |
|
|
2015
Q4 | $15.4K | Sell |
963
-1,202
| -56% | -$18.3K | ﹤0.01% | 3055 |
|
|
2015
Q3 | $25.9K | Buy |
2,165
+1,349
| +165% | +$17.9K | ﹤0.01% | 3230 |
|
|
2015
Q2 | $11.6K | Buy |
816
+595
| +269% | +$8.43K | ﹤0.01% | 3302 |
|
|
2015
Q1 | $3.18K | Buy |
+221
| New | +$3.12K | ﹤0.01% | 3363 |
|
|
2014
Q4 | – | Sell |
-669
| Closed | -$8.7K | – | 2795 |
|
|
2014
Q3 | $8.7K | Buy |
669
+657
| +5,475% | +$9.04K | ﹤0.01% | 3653 |
|
|
2014
Q2 | $168 | Buy |
+12
| New | +$181 | ﹤0.01% | 3724 |
|
|
2014
Q1 | – | Sell |
-127
| Closed | -$2.39K | – | 3685 |
|
|
2013
Q4 | $2.39K | Buy |
+127
| New | +$2.23K | ﹤0.01% | 3576 |
|
Other funds holding NRC
WIC
QI
BNP Paribas Financial Markets's NRC Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its NRC Health Common Stock (NRC) stake by 58% in Q2 2026, buying an estimated $27.8K and bringing the position to 4,096 shares worth $88.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4622.
BNP Paribas Financial Markets first reported a position in NRC in Q4 2013 and has held it in 48 quarters since. The position peaked at $667K in Q2 2024. 123 funds tracked by Wall St. Rank hold NRC as of Q2 2026.
- BNP Paribas Financial Markets held 4,096 shares of NRC Health Common Stock worth $88.4K as of Q2 2026.
- BNP Paribas Financial Markets bought 1,497 NRC Health Common Stock shares in Q2 2026, an estimated $27.8K.
- NRC Health Common Stock made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4622 holding.
- BNP Paribas Financial Markets first reported a position in NRC Health Common Stock in Q4 2013 and has held it in 48 quarters since.
- BNP Paribas Financial Markets's NRC Health Common Stock position peaked at $667K in Q2 2024.
- 123 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.